Yadi Liu, Zhongyan Sun, Ruixue Dong, Peiyu Liu, Xi Zhang, Yiran Li, Xiaoshan Lai, Hio-Fai Cheong, Yuwei Wu, Yilin Wang, Hua Zhou, Dingkun Gui, Youhua Xu
BACKGROUND: In diabetic liver injury, nonalcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease. Rutin is a bioflavonoid produced by the hydrolysis of glucosidases to quercetin. Its biological activities include lowering blood glucose, regulating insulin secretion, regulating dyslipidemia, and exerting anti-inflammatory effects have been demonstrated. However, its effect on diabetic NAFLD is rarely reported. PURPOSE: Our study aimed to investigate the protective effects of Rutin on diabetic NAFLD and potential pharmacological mechanism...
February 9, 2024: Phytomedicine